Literature DB >> 7670541

Proteins anchored via glycosylphosphatidylinositol and solubilizing phospholipases in Trypanosoma cruzi.

M L de Almeida1, N Heise.   

Abstract

The presence of GPI anchors and phospholipases capable of solubilizing them in Trypanosoma cruzi has been investigated in epimastigotes, metacyclic trypomastigotes from axenic cultures and tissue culture trypomastigotes. The GPI anchored proteins in epimastigote forms are scarce when compared to their abundance in the parasite forms which can infect mammals, and GPI-solubilizing phospholipases C have been found in all life cycles stages. In epimastigote and metacyclic forms, the activity is found in the soluble fraction upon cell lysis, whereas in tissue cultured trypomastigotes it is membrane bound and, being mostly sensitive to p-chloromercuriphenylsulfonate, resembles closely the GPI specific phospholipase of Trypanosoma brucei. Sequential immunoprecipitations with monoclonal antibodies and anti-CRD indicated the presence of several sub-populations among the surface proteins of metacyclic trypomastigotes, five of these belonging to the GPI-anchored 90 kD family. Among this family, the epitopes recognized by MAb-1G7 are present in three members, one of them also expressing the 3F6 epitope. There are 2 members recognized only by MAb-3F6 but not by MAb-1G7, one of them being probably galactosylated on the GPI since it can be immunoprecipitated by anti-CRD. Very strangely, the epitope recognized by the MAb-WIC29.26 was always present on the gp72, as originally described, but under certain circumstances appeared cryptic on one of the 90 kD species. During epimastigote transformation into metacyclic trypomastigotes in vitro, the ability of the GPI of the 1G7-antigen to be solubilized by phospholipase C and D varies depending on the age of the culture and presence or absence of fetal calf serum. Different patterns of solubilization were also obtained for 1G7-Ag, depending on whether the test is performed with parasite lysates or with antigen affinity purified from them. Our data indicate that the phospholipase C resistance observed does not arise from acylation on the inositol, as previously described for acetylcholinesterase from human erythrocytes, being rather due to factors which either modify the GPI or affect the action of the phospholipases. Previously unreported resistance to glycosylphosphatidylinositol-specific phospholipase D has been observed both to glycosylphosphatidylinositol-specific phospholipase D has been observed both to 1G7-Ag and 10D8-Ag, the GPI-anchored mucynlike protein which is acceptor of sialic acid in metacyclic forms. Our findings are discussed in the light of the presently known structures of GPI in this parasite, and imaginative speculation on biological roles for the GPI phospholipase system in T. cruzi is also provided.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7670541

Source DB:  PubMed          Journal:  Biol Res        ISSN: 0716-9760            Impact factor:   5.612


  12 in total

1.  Infectivity of Trypanosoma cruzi strains is associated with differential expression of surface glycoproteins with differential Ca2+ signalling activity.

Authors:  R C Ruiz; S Favoreto; M L Dorta; M E Oshiro; A T Ferreira; P M Manque; N Yoshida
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

2.  Characterization of the inositol phosphorylceramide synthase activity from Trypanosoma cruzi.

Authors:  Juliana M Figueiredo; Wagner B Dias; Lucia Mendonça-Previato; José O Previato; Norton Heise
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

3.  Molecular and functional characterization of the ceramide synthase from Trypanosoma cruzi.

Authors:  Juliana M Figueiredo; Deivid C Rodrigues; Rafael C M C Silva; Carolina M Koeller; James C Jiang; S Michal Jazwinski; José O Previato; Lucia Mendonça-Previato; Turán P Urményi; Norton Heise
Journal:  Mol Biochem Parasitol       Date:  2011-12-30       Impact factor: 1.759

4.  Evidence for phospholipases from Trypanosoma cruzi active on phosphatidylinositol and inositolphosphoceramide.

Authors:  L E Bertello; M J Alves; W Colli; R M de Lederkremer
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

5.  Golgi UDP-GlcNAc:polypeptide O-α-N-Acetyl-d-glucosaminyltransferase 2 (TcOGNT2) regulates trypomastigote production and function in Trypanosoma cruzi.

Authors:  Carolina M Koeller; Hanke van der Wel; Christa L Feasley; Fernanda Abreu; Juliana Dutra Barbosa da Rocha; Fabrício Montalvão; Patrícia Fampa; Flávia C G Dos Reis; Georgia C Atella; Thaís Souto-Padrón; Christopher M West; Norton Heise
Journal:  Eukaryot Cell       Date:  2014-08-01

6.  Proteomic analysis of detergent-solubilized membrane proteins from insect-developmental forms of Trypanosoma cruzi.

Authors:  Esteban M Cordero; Ernesto S Nakayasu; Luciana G Gentil; Nobuko Yoshida; Igor C Almeida; José Franco da Silveira
Journal:  J Proteome Res       Date:  2009-07       Impact factor: 4.466

Review 7.  Genetic structure and expression of the surface glycoprotein GP82, the main adhesin of Trypanosoma cruzi metacyclic trypomastigotes.

Authors:  Paulo Roberto Ceridorio Correa; Esteban Mauricio Cordero; Luciana Girotto Gentil; Ethel Bayer-Santos; José Franco da Silveira
Journal:  ScientificWorldJournal       Date:  2013-02-04

8.  Role of phospholipases in fungal fitness, pathogenicity, and drug development - lessons from cryptococcus neoformans.

Authors:  Julianne Teresa Djordjevic
Journal:  Front Microbiol       Date:  2010-11-11       Impact factor: 5.640

9.  Expression and cellular trafficking of GP82 and GP90 glycoproteins during Trypanosoma cruzi metacyclogenesis.

Authors:  Ethel Bayer-Santos; Narcisa Leal Cunha-e-Silva; Nobuko Yoshida; José Franco da Silveira
Journal:  Parasit Vectors       Date:  2013-05-01       Impact factor: 3.876

Review 10.  Interactions between Trypanosoma cruzi Secreted Proteins and Host Cell Signaling Pathways.

Authors:  Renata Watanabe Costa; Jose F da Silveira; Diana Bahia
Journal:  Front Microbiol       Date:  2016-03-31       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.